Stopping aspirin after 24-28 weeks in low-risk screening
Treatments studied
Part of Women’s health & pregnancy clinical trials.
This trial tests whether women at high risk for preeclampsia can safely stop taking aspirin after 24-28 weeks if their blood test shows a low risk. It aims to avoid unnecessary medication while protecting both mother and baby.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are between 24 and 28 weeks pregnant with a single baby.
- Your first-trimester screening showed a high risk for preterm preeclampsia (over 1 in 100).
- You have been taking 150 mg of aspirin daily since before 17 weeks of pregnancy and have taken it at least half the time.
- A blood test between 24 and 28 weeks shows a low level of certain proteins (sFlt-1/PlGF ratio below 66).
- You speak Norwegian or English fluently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether taking a daily low-dose aspirin can help prevent pregnancy loss and preeclampsia. It's for women who are in early pregnancy and have certain health risks.
This trial tests whether taking low-dose aspirin after giving birth can help people who had preeclampsia. It aims to see if aspirin can lower the risk of future heart problems.
This trial studies whether taking acetyl salicylic acid (aspirin) during pregnancy can reduce problems caused by chronic high blood pressure. It focuses on pregnant people already known to have high blood pressure before or early in pregnancy.
This trial tests whether stopping aspirin use in high-risk pregnant women can be safe. It aims to find the best time to stop taking aspirin to prevent preeclampsia, a condition that causes high blood pressure during pregnancy.
This trial tests whether a shorter course of aspirin can safely prevent preeclampsia in pregnant people who are already at high risk and taking daily aspirin. It aims to find the best time to stop the medication while still protecting both mother and baby.
This trial compares two different doses of aspirin (a common safe medication) to see if one works better at preventing preeclampsia, a pregnancy complication, in women at higher risk. Taking part may help doctors find the best way to protect both you and your baby.
Hear when a new Pre-Eclampsia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.